Frederik C. Roos

Impaired Conduction of Vasodilation Along Arterioles in Connexin40-Deficient Mice

Cor de Wit, Frederik C. Roos, Steffen‐Sebastian Bolz et al. · Circulation Research · 2000 · 336 citations

Life Sciences, Pharmacology, Physiology +17

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Thomas Powles, Piotr Tomczak, Se Hoon Park et al. · The Lancet Oncology · 2022 · 278 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Lack of vascular connexin 40 is associated with hypertension and irregular arteriolar vasomotion

Cor de Wit, Frederik C. Roos, Steffen‐Sebastian Bolz et al. · Physiological Genomics · 2003 · 202 citations

Life Sciences, Pharmacology, Physiology +15

Small Renal Tumors: Correlation of Clinical and Pathological Features With Tumor Size

Sascha Pahernik, Stefanie Ziegler, Frederik C. Roos et al. · The Journal of Urology · 2007 · 165 citations

Medicine, Oncology, Surgery +17

Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma – A multicentre study

Sandra Steffens, Martin Janssen, Frederik C. Roos et al. · European Journal of Cancer · 2012 · 144 citations · Full text

Medicine, Oncology, Urology +15